↓ Skip to main content

Cochrane Database of Systematic Reviews

Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
147 Mendeley
Title
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd008079.pub2
Pubmed ID
Authors

Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert, Nicole Skoetz

Abstract

Chronic lymphocytic leukaemia (CLL) accounts for 25% of all leukaemias and is the most common lymphoid malignancy in western countries. Standard treatments include mono- or polychemotherapies, usually combined with monoclonal antibodies such as rituximab or alemtuzumab. However, the impact of these agents remains unclear, as there are hints for increased risk of severe infections.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
France 1 <1%
Colombia 1 <1%
Brazil 1 <1%
Russia 1 <1%
Croatia 1 <1%
Unknown 140 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 15%
Researcher 22 15%
Student > Bachelor 18 12%
Student > Ph. D. Student 16 11%
Other 12 8%
Other 28 19%
Unknown 29 20%
Readers by discipline Count As %
Medicine and Dentistry 75 51%
Agricultural and Biological Sciences 8 5%
Nursing and Health Professions 8 5%
Biochemistry, Genetics and Molecular Biology 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 13 9%
Unknown 30 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2013.
All research outputs
#3,281,807
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#5,627
of 8,923 outputs
Outputs of similar age
#62,876
of 253,963 outputs
Outputs of similar age from Cochrane database of systematic reviews
#285
of 446 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 446 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.